Skip to main content
SpringerLink
Log in

Janus kinase inhibitor-related thromboembolic events

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. immune-mediated diseases

Reference

  • Setyawan J, et al. Reporting of Thromboembolic Events with JAK Inhibitors: Analysis of the FAERS Database 2010-2019. Drug Safety : 13 Jun 2021. Available from: URL: http://doi.org/10.1007/s40264-021-01082-y

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Janus kinase inhibitor-related thromboembolic events. Reactions Weekly 1861, 11 (2021). https://doi.org/10.1007/s40278-021-97811-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-021-97811-0

Search

Navigation